These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33000181)

  • 1. GSK‑3β inhibition promotes doxorubicin‑induced apoptosis in human cholangiocarcinoma cells via FAK/AKT inhibition.
    Li L; Xiang Y; Zeng Y; Xiao B; Yu W; Duan C; Xia X; Zhang T; Zeng Y; Liu Y; Dai R
    Mol Med Rep; 2020 Nov; 22(5):4432-4441. PubMed ID: 33000181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cucurbitacin B induces mitochondrial-mediated apoptosis pathway in cholangiocarcinoma cells via suppressing focal adhesion kinase signaling.
    Klungsaeng S; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Mar; 392(3):271-278. PubMed ID: 30470919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Modulation of FAK/PI3K/PDK1/AKT and FAK/p53 Pathways by Cucurbitacin B for the Antiproliferation Effect Against Human Cholangiocarcinoma Cells.
    Klungsaeng S; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L
    Am J Chin Med; 2020; 48(6):1475-1489. PubMed ID: 32907364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A PLCB1-PI3K-AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression.
    Liang S; Guo H; Ma K; Li X; Wu D; Wang Y; Wang W; Zhang S; Cui Y; Liu Y; Sun L; Zhang B; Xin M; Zhang N; Zhou H; Liu Y; Wang J; Liu L
    Cancer Res; 2021 Dec; 81(23):5889-5903. PubMed ID: 34580062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound C induces protective autophagy in human cholangiocarcinoma cells via Akt/mTOR-independent pathway.
    Zhao X; Luo G; Cheng Y; Yu W; Chen R; Xiao B; Xiang Y; Feng C; Fu W; Duan C; Yao F; Xia X; Tao Q; Wei M; Dai R
    J Cell Biochem; 2018 Jul; 119(7):5538-5550. PubMed ID: 29384220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma.
    Huang GL; Shen DY; Cai CF; Zhang QY; Ren HY; Chen QX
    World J Gastroenterol; 2015 Jan; 21(4):1148-57. PubMed ID: 25632187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cucurbitacin B Diminishes Metastatic Behavior of Cholangiocarcinoma Cells by Suppressing Focal Adhesion Kinase.
    Kaewmeesri P; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):219-225. PubMed ID: 33507702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib.
    Yokoi K; Kobayashi A; Motoyama H; Kitazawa M; Shimizu A; Notake T; Yokoyama T; Matsumura T; Takeoka M; Miyagawa SI
    Oncol Rep; 2018 Feb; 39(2):843-850. PubMed ID: 29251327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma.
    Song F; Hu B; Cheng JW; Sun YF; Zhou KQ; Wang PX; Guo W; Zhou J; Fan J; Chen Z; Yang XR
    Cell Death Dis; 2020 Jul; 11(7):573. PubMed ID: 32709873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
    Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
    Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion.
    Dana P; Saisomboon S; Kariya R; Okada S; Obchoei S; Sawanyawisuth K; Wongkham C; Pairojkul C; Wongkham S; Vaeteewoottacharn K
    Cell Oncol (Dordr); 2020 Apr; 43(2):211-222. PubMed ID: 31729681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.
    Srijiwangsa P; Ponnikorn S; Na-Bangchang K
    BMC Pharmacol Toxicol; 2018 Jun; 19(1):32. PubMed ID: 29914576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salubrinal Enhances Doxorubicin Sensitivity in Human Cholangiocarcinoma Cells Through Promoting DNA Damage.
    Yu W; Xiang Y; Luo G; Zhao X; Xiao B; Cheng Y; Feng C; Duan C; Xia X; Wong VKW; Dai R
    Cancer Biother Radiopharm; 2018 Aug; 33(6):258-265. PubMed ID: 29957018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nobiletin suppresses cholangiocarcinoma proliferation via inhibiting GSK3β.
    You L; Lin J; Yu Z; Qian Y; Bi Y; Wang F; Zhang L; Zheng C; Zhang J; Li W; Cai Y; Gao Y; Kong X; Sun X
    Int J Biol Sci; 2022; 18(15):5698-5712. PubMed ID: 36263164
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein.
    Saikawa S; Kaji K; Nishimura N; Seki K; Sato S; Nakanishi K; Kitagawa K; Kawaratani H; Kitade M; Moriya K; Namisaki T; Mitoro A; Yoshiji H
    Cancer Lett; 2018 Oct; 434():120-129. PubMed ID: 30031758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway.
    Thongchot S; Vidoni C; Ferraresi A; Loilome W; Yongvanit P; Namwat N; Isidoro C
    Mol Carcinog; 2018 Dec; 57(12):1735-1750. PubMed ID: 30136419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates.
    Li S; Zhou Y; Wang R; Zhang H; Dong Y; Ip C
    Mol Cancer Ther; 2007 Mar; 6(3):1031-8. PubMed ID: 17339365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antitumor activity of the combination of salubrinal and rapamycin against human cholangiocarcinoma cells.
    Zhao X; Zhang C; Zhou H; Xiao B; Cheng Y; Wang J; Yao F; Duan C; Chen R; Liu Y; Feng C; Li H; Li J; Dai R
    Oncotarget; 2016 Dec; 7(51):85492-85501. PubMed ID: 27863431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway.
    Wandee J; Prawan A; Senggunprai L; Kongpetch S; Tusskorn O; Kukongviriyapan V
    Life Sci; 2018 Aug; 207():172-183. PubMed ID: 29847773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.